Title:

DRUG HOUSES OF AUSTRALIA (ASIA) PTE. LTD.-COMPANY REPORT

Price:$1,400.00
Publication Date:Nov 07, 2007
Source:LIFE SCIENCE ANALYTICS
Author:HARINATHA, G.
Brief Excerpt:...Drug Houses of Australia (Asia) Pte. Ltd. (DHA), a wholly-owned subsidiary of Haw Par Healthcare, is a leading name among manufacturers of pharmaceutical pr oducts. The company was established in ####. Its philosophy is to provide reliable and quality pharmaceutic al products through stringent quality control. DHA's laboratory is equipped with state-of-the-art testing equipment such as gas chromatographs, liquid chromatographs, atomic absorption spectrophotomet er, ultra-violet-spectroph otometers, FT-infra-red spectrophotometer, tablet-t esting machine, autotitrators and other analytical instruments. DHA manufactures Tablets (plain, coated), Capsules, Cr eams/ Ointments, Granules/ Powders, Liquid preparations- syrups, suspensions, emulsions and so lutions. The company also produces contract manufacture OTC products and Chinese Proprietary Medici nes (CPM). DHA markets and distributes its products to Private clinics & Group practices, Hospital s (private and restructured)...
Length:35 Pages
Company:DRUG HOUSES OF AUSTRALIA ASIA PTE LTD
Geographic Regions:ASIAN CONTINENT, SOUTHEAST ASIA, SINGAPORE
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Company Information11
Drug Houses of Australia (Asia) Pte. Ltd. [NonUS -- Symbol : Private]11
Formation Date: 196911
Business Summary11
Product Glance31
Diseasehub Classification31
Product Summary43
Product Details71
1. Cementin (cimetidine)71
Description75
Therapeutic71
Drug Class71
Trial Details81
Last Updated81
Current Trial818
Therapeutic91
Drug Class91
6. Zendhin (ranitidine hydrochloride)91
Last Updated101
9. Zenmolin (salbutamol sulphate)101
10. Glibenclamide101
Trial Details111
Therapeutic119
Drug Class111
Last Updated122
19. Doridone (domperidone)121
20. Metoclopramide131
Description131
Drug Class133
26. DHA- Simvastatin141
Last Updated151
Trial Details153
Description163
Last Updated171
34. Propylthiouracil171
38. DHA- Clarithromycin181
Drug Class185
40. Dhatracin (tetracycline hydrochloride)191
Trial Details194
Last Updated192
44. Trizine (timethoprim, sulphadiazine)201
Description202
Last Updated2214
51. Dhacold (paracetamol, pseudoephedrine, chlorpheniramine maleate, caffeine)221
Therapeutic221
54. Dhactulose (lactulose)231
57. Pharynx lozenges (benzocaine, cetylpyridinium chloride)231
Trial Details241
58. Glycerin thymol gargle (glycerin, methyl salicylate, thymol menthol, borax, sodium salicylate, sodium benzoate)241
Therapeutic241
63. Dhacodine (pholcodine)251
Description254
Drug Class257
65. Dhasedyl DM (dextromethorphan Hbr, promethazine HCl, ephedrine HCl )261
Trial Details261
Current Trial271
71. Promethazine271
72. Vasican (bromhexine HCl)281
73. Betasone (betamethasone)281
Current Trial291
Trial Details292
Therapeutic296
80. Difenac (diclofenac sodium )301
Description302
Current Trial314
83. Picapan (paracetamol, caffeine)311
Trial Details323
87. DHA-Glucosamine sulphate321
90. Natural vitamin E 400IU licap331
Description332
Tables
TitleStarting PageNumber of Pages
of Contents21

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $1,400.00




TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions